L'Oreal USA
L'Oreal USA appears in FDA public data with 3 recalls, 0 510(k) clearances, 10 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0419-2025, Class II) was initiated on March 5, 2025.
Summary
- Total Recalls
- 3
- 510(k) Clearances
- 0
- Inspections
- 10
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0419-2025 | Class II | La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Pero | March 5, 2025 |
| D-0418-2025 | Class II | La Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne System, 3 Step Acne Routine K | March 5, 2025 |
| D-0417-2025 | Class II | La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Pero | March 5, 2025 |